1. Home
  2. CRVS vs LPTH Comparison

CRVS vs LPTH Comparison

Compare CRVS & LPTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$14.46

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo LightPath Technologies Inc.

LPTH

LightPath Technologies Inc.

HOLD

Current Price

$14.42

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRVS
LPTH
Founded
2014
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2016
2011

Fundamental Metrics

Financial Performance
Metric
CRVS
LPTH
Price
$14.46
$14.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
3
Target Price
$30.17
$13.33
AVG Volume (30 Days)
803.7K
2.6M
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
48.04
N/A
EPS
N/A
N/A
Revenue
N/A
$37,202,630.00
Revenue This Year
N/A
$83.04
Revenue Next Year
N/A
$24.83
P/E Ratio
N/A
N/A
Revenue Growth
N/A
17.26
52 Week Low
$5.29
$4.18
52 Week High
$26.95
$18.94

Technical Indicators

Market Signals
Indicator
CRVS
LPTH
Relative Strength Index (RSI) 51.76 55.75
Support Level $14.24 $9.85
Resistance Level $16.66 $16.06
Average True Range (ATR) 0.73 1.02
MACD 0.04 0.18
Stochastic Oscillator 57.19 59.85

Price Performance

Historical Comparison
CRVS
LPTH

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

About LPTH LightPath Technologies Inc.

LightPath Technologies Inc manufactures, distributes, and integrates proprietary optical components and assemblies. It develops optical solutions for traditional optics and communications markets. The company's products include precision molded optics and infrared products, serving markets such as distribution, laser, industrial, instrumentation, telecommunications, and defense. Its products are categorized as infrared components, visible components, assemblies and modules, and engineering services. G5 Infrared's revenue mainly comes from infrared components and assemblies.

Share on Social Networks: